CARGO Therapeutics, Inc. Common Stock

NASDAQ CRGX
- - -%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 13.75 %
Market cap Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.
194.76M
EV Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
135.49M
Beta Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
-
Shares Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
47.85M
YTD Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-

Upcoming events CARGO Therapeutics, Inc. Common Stock

All events
No upcoming events scheduled

Stock chart CARGO Therapeutics, Inc. Common Stock

Stock analysis CARGO Therapeutics, Inc. Common Stock

Indicator Company Industry
P/E (LTM) Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-0.90 -1.30
P/BV (LTM) Shows the ratio of the market price of the share to the current book value.
1.80 1.15
EV/EBITDA (LTM) Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-0.71 -0.75
Net Debt/EBITDA (LTM) A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
0.31 0.42
ROE (LTM) Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-76.54 -50.00

Price change CARGO Therapeutics, Inc. Common Stock per year

3.39$ 25.00$
Min Max

Summary analysis CARGO Therapeutics, Inc. Common Stock

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure CARGO Therapeutics, Inc. Common Stock

Revenue and net income CARGO Therapeutics, Inc. Common Stock

All parameters

About company CARGO Therapeutics, Inc. Common Stock

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is based in San Mateo, California.
Address:
1900 Alameda De Las Pulgas, San Mateo, CA, United States, 94403
Company name: CARGO Therapeutics, Inc. Common Stock
Issuer ticker: CRGX
ISIN: US14179K1016
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2023-11-10
Sector: Healthcare
Industry: Biotechnology
Site: https://cargo-tx.com